Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,830.00    2.00 (0.07%)
Bid:
2,828.00
Ask:
2,830.00
Spread: 2.00 (0.071%)
Market Cap: £6.73b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Director/PDMR Shareholding

20 Aug 2025 16:00

RNS Number : 1405W
IMI PLC
20 August 2025
 

20 August 2025

 

IMI PLC(the "Company")

Notification of Transactions by a Person Discharging Managerial Responsibilities ("PDMR") and a Person Closely Associated ("PCA") with them

On 19 August 2025, a performance share award was granted under the terms of the IMI Incentive Plan to Luke Grant, Chief Financial Officer. On the same day, Luke's PCA, Ruth Grant (a previous employee of the Company), exercised an award made under the Restricted Stock Unit of the IMI Incentive Plan and subsequently sold a sufficient number of shares to cover tax liabilities and associated costs:

This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Luke Grant

 

2.

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IMI plc

b)

LEI

2138002W9Q21PF751R30

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary share GB00BGLP8L22

b)

Nature of the transaction

Grant of performance shares under the IMI Incentive Plan. No consideration is payable on the grant, vesting or exercise of the awards.

 c)

Price(s) and volume(s)

Price(s)

Volume(s)

nil

38,412

d)

Aggregated information

· Aggregated volume

· Price

 

nil

38,412

e)

Date of the transaction

19 August 2025

f)

Place of the transaction

Outside of a trading venue

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Ruth Grant

 

2.

Reason for the notification

a)

Position/status

Person Closely Associated with Luke Grant, Chief Financial Officer

b)

Initial notification/ Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IMI plc

b)

LEI

2138002W9Q21PF751R30

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument Identification code

Ordinary share GB00BGLP8L22

b)

Nature of the transaction

i) Exercise of Restricted Stock Unit ("RSU") as granted under the IMI Incentive Plan

ii) Sale of Restricted Stock Unit as granted under the IMI Incentive Plan

 c)

Price(s) and volume(s)

Price(s)

Volume(s)

i)

nil

572

ii)

£23.007

271

d)

Aggregated information

· Aggregated volume

· Price

N/A

e)

Date of the transaction

19 August 2025

f)

Place of the transaction

RSU exercised outside of trading venue

Shares sold on London Stock Exchange Main Market (XLON)

 

For further information, please contact:

 

Fran Burge

Deputy Company SecretaryTelephone: 0121 717 3700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEAFLSEISEIA
Date   Source Headline
8th Apr 20222:53 pmRNSDirector/PDMR Shareholding
1st Apr 202210:39 amRNSTotal Voting Rights
31st Mar 20224:04 pmRNSDirector/PDMR Shareholding
31st Mar 20229:17 amRNSHolding(s) in Company
30th Mar 20226:03 pmRNSDirector/PDMR Shareholding
30th Mar 20226:02 pmRNSDirector/PDMR Shareholding
30th Mar 20225:58 pmRNSDirector/PDMR Shareholding
30th Mar 20225:57 pmRNSDirector/PDMR Shareholding
30th Mar 20225:53 pmRNSDirector/PDMR Shareholding
30th Mar 20225:49 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSDirector/PDMR Shareholding
25th Mar 20224:21 pmRNSAnnual Financial Report
22nd Mar 20225:32 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:30 pmRNSDirector/PDMR Shareholding
9th Mar 20224:52 pmRNSDirector/PDMR Shareholding
9th Mar 20224:51 pmRNSDirector/PDMR Shareholding
9th Mar 20224:49 pmRNSDirector/PDMR Shareholding
8th Mar 20223:09 pmRNSHolding(s) in Company
7th Mar 20222:24 pmRNSDirector/PDMR Shareholding
1st Mar 20225:37 pmRNSDirector/PDMR Shareholding
1st Mar 202211:00 amRNSTotal Voting Rights
25th Feb 20227:00 amRNSPreliminary results, year ended 31 December 2021
10th Feb 202210:53 amRNSHolding(s) in Company
9th Feb 20225:20 pmRNSDirector/PDMR Shareholding
9th Feb 20225:19 pmRNSDirector/PDMR Shareholding
9th Feb 20225:15 pmRNSDirector/PDMR Shareholding
1st Feb 202211:25 amRNSTotal Voting Rights
25th Jan 20223:27 pmRNSHolding(s) in Company
12th Jan 20222:04 pmRNSDirector/PDMR Shareholding
12th Jan 20222:01 pmRNSDirector/PDMR Shareholding
12th Jan 20221:58 pmRNSDirector/PDMR Shareholding
12th Jan 20221:54 pmRNSDirector/PDMR Shareholding
4th Jan 20224:59 pmRNSBlock listing Interim Review
4th Jan 202211:55 amRNSTotal Voting Rights
20th Dec 20217:00 amRNSCompletion of Adaptas Solutions acquisition
15th Dec 20214:53 pmRNSDirector/PDMR Shareholding
15th Dec 20214:51 pmRNSDirector/PDMR Shareholding
15th Dec 20214:48 pmRNSDirector/PDMR Shareholding
15th Dec 20214:37 pmRNSDirector/PDMR Shareholding
1st Dec 20213:30 pmRNSTotal Voting Rights
23rd Nov 20216:14 pmRNSTransaction in Own Shares
22nd Nov 20216:22 pmRNSTransaction in Own Shares
19th Nov 20216:01 pmRNSTransaction in Own Shares
18th Nov 20216:04 pmRNSTransaction in Own Shares
17th Nov 20216:04 pmRNSTransaction in Own Shares
16th Nov 20216:03 pmRNSTransaction in Own Shares
15th Nov 20217:00 amRNSProposed acquisition of Adaptas Solutions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.